Business Development Manager
Biocytogen
Business Development Manager
Biocytogen
Antibody discovery and preclinical CRO services
Biocytogen · Madison, United States (Remote) · Full-time · Posted 2026-09-09
Salary: USD 100,000–110,000
Workplace: remote
Department: Reg3MS
Biocytogen is a fast-growing biotech company with broad cutting-edge technologies. You will have the best opportunity to learn and utilize the science and business in the fields of immuno-oncology, animal model gene engineering, preclinical pharmacology, etc. The biggest advantage of working in Biocytogen is that your career will have the best combination of biopharmaceutical science and applications, and you will grow with Biocytogen with confidence and strength.
BIOCYTOGEN is an Equal Opportunity Employer. Employment opportunities at BIOCYTOGEN BOSTON CORP are based upon one’s qualifications and capabilities to perform the essential functions of a particular job. All employment opportunities are provided without regard to race, color religion, sex, national origin, ancestry, age, sexual orientation, gender identity and expression, veteran status, military status, disability, mental illness, genetic information, or any other characteristic protected by law. This Equal Employment Opportunity policy governs all aspects of employment, including, but not limited to, recruitment, hiring, selection, job assignment, promotions, transfers, compensation, discipline, termination, layoff, access to benefits and training, and all other conditions and privileges of employment.
Powered by Workable
Antibody discovery and preclinical CRO services
Biocytogen provides integrated solutions for antibody-based drug research and development, with two main divisions: BioMice for preclinical CRO services and antibody discovery/licensing. Its RenMice platforms (RenMab, RenLite, RenNano) generate fully human antibodies using Size-Unlimited and Precise Chromosome Engineering, backed by a large off-the-shelf antibody library from Project Integrum to streamline discovery. The company combines gene-edited humanized mouse models with an extensive antibody library in an end-to-end pipeline, differentiating itself by offering rapid progression from target to therapeutic antibody and co-development/licensing options. Its goal is to discover and develop antibody drugs for more than 1,000 targets and become a leading provider of antibody discovery and preclinical services.
Explore more opportunities at Biocytogen